Literature DB >> 22710064

Intranuclear matrix metalloproteinases promote DNA damage and apoptosis induced by oxygen-glucose deprivation in neurons.

J W Hill1, R Poddar, J F Thompson, G A Rosenberg, Y Yang.   

Abstract

Degradation of the extracellular matrix by elevated matrix metalloproteinase (MMP) activity following ischemia/reperfusion is implicated in blood-brain barrier disruption and neuronal death. In contrast to their characterized extracellular roles, we previously reported that elevated intranuclear MMP-2 and -9 (gelatinase) activity degrades nuclear DNA repair proteins and promotes accumulation of oxidative DNA damage in neurons in rat brain at 3-h reperfusion after ischemic stroke. Here, we report that treatment with a broad-spectrum MMP inhibitor significantly reduced neuronal apoptosis in rat ischemic hemispheres at 48-h reperfusion after a 90-min middle cerebral artery occlusion (MCAO). Since extracellular gelatinases in brain tissue are known to be neurotoxic during acute stroke, the contribution of intranuclear MMP-2 and -9 activities in neurons to neuronal apoptosis has been unclear. To confirm and extend our in vivo observations, oxygen-glucose deprivation (OGD), an in vitro model of ischemia/reperfusion, was employed. Primary cortical neurons were subjected to 2-h OGD with reoxygenation. Increased intranuclear gelatinase activity was detected immediately after reoxygenation onset and was maximal at 24h, while extracellular gelatinase levels remained unchanged. We detected elevated levels of both MMP-2 and -9 in neuronal nuclear extracts and gelatinase activity in neurons co-localized primarily with MMP-2. We found a marked decrease in PARP1, XRCC1, and OGG1, and decreased PARP1 activity. Pretreatment of neurons with selective MMP-2/9 inhibitor II significantly decreased gelatinase activity and downregulation of DNA repair enzymes, decreased accumulation of oxidative DNA damage, and promoted neuronal survival after OGD. Our results confirm the nuclear localization of gelatinases and their nuclear substrates observed in an animal stroke model, further supporting a novel role for intranuclear gelatinase activity in an intrinsic apoptotic pathway in neurons during acute stroke injury.
Copyright © 2012 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22710064      PMCID: PMC4546359          DOI: 10.1016/j.neuroscience.2012.06.019

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  44 in total

1.  Matrix metalloproteinase inhibition prevents oxidative stress-associated blood-brain barrier disruption after transient focal cerebral ischemia.

Authors:  Y Gasche; J C Copin; T Sugawara; M Fujimura; P H Chan
Journal:  J Cereb Blood Flow Metab       Date:  2001-12       Impact factor: 6.200

2.  beta-Amyloid (1-40)-induced apoptosis of cultured cortical neurones involves calpain-mediated cleavage of poly-ADP-ribose polymerase.

Authors:  Barry Boland; Veronica Campbell
Journal:  Neurobiol Aging       Date:  2003 Jan-Feb       Impact factor: 4.673

3.  Hemoglobin-induced oxidative stress contributes to matrix metalloproteinase activation and blood-brain barrier dysfunction in vivo.

Authors:  Masataka Katsu; Kuniyasu Niizuma; Hideyuki Yoshioka; Nobuya Okami; Hiroyuki Sakata; Pak H Chan
Journal:  J Cereb Blood Flow Metab       Date:  2010-03-31       Impact factor: 6.200

4.  Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size.

Authors:  A M Romanic; R F White; A J Arleth; E H Ohlstein; F C Barone
Journal:  Stroke       Date:  1998-05       Impact factor: 7.914

5.  Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain: activation of MMP-9 linked to stromelysin-1 and microglia in cell cultures.

Authors:  G A Rosenberg; L A Cunningham; J Wallace; S Alexander; E Y Estrada; M Grossetete; A Razhagi; K Miller; A Gearing
Journal:  Brain Res       Date:  2001-03-02       Impact factor: 3.252

Review 6.  Molecular insights and therapeutic targets for blood-brain barrier disruption in ischemic stroke: critical role of matrix metalloproteinases and tissue-type plasminogen activator.

Authors:  Rong Jin; Guojun Yang; Guohong Li
Journal:  Neurobiol Dis       Date:  2010-03-17       Impact factor: 5.996

7.  Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94.

Authors:  M Asahi; K Asahi; J C Jung; G J del Zoppo; M E Fini; E H Lo
Journal:  J Cereb Blood Flow Metab       Date:  2000-12       Impact factor: 6.200

8.  Poly(ADP-ribose) polymerase-1 promotes microglial activation, proliferation, and matrix metalloproteinase-9-mediated neuron death.

Authors:  Tiina M Kauppinen; Raymond A Swanson
Journal:  J Immunol       Date:  2005-02-15       Impact factor: 5.422

9.  Matrix metalloproteinase-2 (MMP-2) is present in the nucleus of cardiac myocytes and is capable of cleaving poly (ADP-ribose) polymerase (PARP) in vitro.

Authors:  Jennifer A Kwan; Costas J Schulze; Wenjie Wang; Hernando Leon; Meltem Sariahmetoglu; Miranda Sung; Jolanta Sawicka; David E Sims; Grzegorz Sawicki; Richard Schulz
Journal:  FASEB J       Date:  2004-02-06       Impact factor: 5.191

10.  S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death.

Authors:  Zezong Gu; Marcus Kaul; Boxu Yan; Steven J Kridel; Jiankun Cui; Alex Strongin; Jeffrey W Smith; Robert C Liddington; Stuart A Lipton
Journal:  Science       Date:  2002-08-16       Impact factor: 47.728

View more
  35 in total

Review 1.  Oxidative stress and DNA damage after cerebral ischemia: Potential therapeutic targets to repair the genome and improve stroke recovery.

Authors:  Peiying Li; R Anne Stetler; Rehana K Leak; Yejie Shi; Yan Li; Weifeng Yu; Michael V L Bennett; Jun Chen
Journal:  Neuropharmacology       Date:  2017-11-08       Impact factor: 5.250

Review 2.  Targeting matrix metalloproteinase activity and expression for the treatment of viral myocarditis.

Authors:  Reid G Hendry; Leanne M Bilawchuk; David J Marchant
Journal:  J Cardiovasc Transl Res       Date:  2014-01-01       Impact factor: 4.132

3.  Matrix Metalloproteinase 9 and Osteopontin Interact to Support Synaptogenesis in the Olfactory Bulb after Mild Traumatic Brain Injury.

Authors:  Melissa A Powell; Raiford T Black; Terry L Smith; Thomas M Reeves; Linda L Phillips
Journal:  J Neurotrauma       Date:  2019-01-10       Impact factor: 5.269

4.  The role of iNOS in cholesterol-induced liver fibrosis.

Authors:  Sarit Anavi; Michal Eisenberg-Bord; Michal Hahn-Obercyger; Olga Genin; Mark Pines; Oren Tirosh
Journal:  Lab Invest       Date:  2015-06-22       Impact factor: 5.662

Review 5.  Matrix metalloproteinases as therapeutic targets for stroke.

Authors:  Yi Yang; Gary A Rosenberg
Journal:  Brain Res       Date:  2015-04-25       Impact factor: 3.252

6.  Tissue- and cell-specific co-localization of intracellular gelatinolytic activity and matrix metalloproteinase 2.

Authors:  Ann Iren Solli; Bodil Fadnes; Jan-Olof Winberg; Lars Uhlin-Hansen; Elin Hadler-Olsen
Journal:  J Histochem Cytochem       Date:  2013-03-12       Impact factor: 2.479

7.  Cerebrospinal fluid ceramides from patients with multiple sclerosis impair neuronal bioenergetics.

Authors:  Oscar G Vidaurre; Jeffery D Haines; Ilana Katz Sand; Kadidia P Adula; Jimmy L Huynh; Corey A McGraw; Fan Zhang; Merina Varghese; Elias Sotirchos; Pavan Bhargava; Veera Venkata Ratnam Bandaru; Giulio Pasinetti; Weijia Zhang; Matilde Inglese; Peter A Calabresi; Gang Wu; Aaron E Miller; Norman J Haughey; Fred D Lublin; Patrizia Casaccia
Journal:  Brain       Date:  2014-06-03       Impact factor: 13.501

8.  Early inhibition of MMP activity in ischemic rat brain promotes expression of tight junction proteins and angiogenesis during recovery.

Authors:  Yi Yang; Jeffrey F Thompson; Saeid Taheri; Victor M Salayandia; Thera A McAvoy; Jeff W Hill; Yirong Yang; Eduardo Y Estrada; Gary A Rosenberg
Journal:  J Cereb Blood Flow Metab       Date:  2013-04-10       Impact factor: 6.200

9.  Bax inhibiting peptide reduces apoptosis in neonatal rat hypoxic-ischemic brain damage.

Authors:  Meng-Ya Sun; Kai-Jie Cui; Mao-Min Yu; Hui Zhang; Xiang-Li Peng; Hong Jiang
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

10.  Ergosta-7,9(11),22-trien-3β-ol Alleviates Intracerebral Hemorrhage-Induced Brain Injury and BV-2 Microglial Activation.

Authors:  Po-Jen Hsueh; Mong-Heng Wang; Che-Jen Hsiao; Chih-Kuang Chen; Fan-Li Lin; Shu-Hsien Huang; Jing-Lun Yen; Ping-Huei Tsai; Yueh-Hsiung Kuo; George Hsiao
Journal:  Molecules       Date:  2021-05-17       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.